|
"tsou hh"的相关文件
显示项目 76-100 / 109 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2012-09-25 |
A pilot randomized controlled trial to improve geriatric frailty
|
Chan, DC;Tsou, HH;Yang, RS;Tsauo, JY;Chen, CY;Hsiung, CA;Kuo, K |
| 國家衛生研究院 |
2012-09-04 |
Assessment of regional treatment effect in a multiregional clinical trial
|
Tsong, Y;Chang, WJ;Dong, X;Tsou, HH |
| 國家衛生研究院 |
2012-09 |
Putative tumor metastasis-associated genes in human gastric cancer
|
Tuan, TF;Chung, CT;Tsou, HH;Chen, FW;Lin, HL;Lai, YK;Lee, WS;Chao, YS;Hwang, LL;Chen, CT |
| 國家衛生研究院 |
2012-09 |
Weighted evidence approach of bridging study
|
Tsou, HH;Tsong, Y;Liu, JT;Dong, XY;Wu, YT |
| 國家衛生研究院 |
2012-09 |
Design and analysis issues of multiregional clinical trials with different regional primary endpoints
|
Tsou, HH;Tsong, Y;Chang, WJ;Dong, X;Hsiao, CF |
| 國家衛生研究院 |
2012-07-26 |
Multiregional Clinical Trials
|
Tsong, Y;Tsou, HH |
| 國家衛生研究院 |
2012-07-26 |
A bayesian approach for evaluation of bridging studies
|
Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ |
| 國家衛生研究院 |
2012-07-26 |
Two-stage designs of bridging studies
|
Hsiao, CF;Tsou, HH;Liu, JP;Wu, YJ |
| 國家衛生研究院 |
2012-07 |
Establishing consistency across all regions in a multi-regional clinical trial
|
Tsou, HH;James Hung, HM;Chen, YM;Huang, WS;Chang, WJ;Hsiao, CF |
| 國家衛生研究院 |
2012-06 |
UGT2B7 genetic polymorphisms are associated with the withdrawal symptoms in methadone maintenance patients
|
Tian, JN;Ho, IK;Tsou, HH;Fang, CP;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, YT;Liu, SC;Hsu, YT;Kuo, HW;Liu, CT;Yang, YT;Chen, A;Shih, YH;Liu, YL |
| 國家衛生研究院 |
2011-10 |
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients
|
Chen, CH;Wang, SC;Tsou, HH;Ho, IK;Tian, JN;Yu, CJ;Hsiao, CF;Chou, SY;Lin, YF;Fang, KC;Huang, CL;Su, LW;Fang, YC;Liu, ML;Lin, KM;Hsu, YT;Liu, SC;Chen, AC;Liu, YL |
| 中國醫藥大學 |
2011-10 |
Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients
|
(Chen CH);(Wang SC);(Tsou HH);(Ho IK);(Tian JN);(Yu CJ);(Hsiao CF);(Chou SY);(Lin YF);(Fang KC);黃介良(Chieh-Liang Huang);(Su LW);(Fang YC);(Liu ML);(Lin KM);(Hsu YT);(Liu SC);(Chen AC);(Liu YL)* |
| 國家衛生研究院 |
2011-09-23 |
A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou
|
Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY |
| 國家衛生研究院 |
2011-08 |
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer
|
Wang, SC;Ho, IK;Tsou, HH;Tian, JN;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Chen, CY;Liu, SC;Wu, HY;Chan, HW;Tsai, MH;Lin, PS;Liu, YL |
| 中國醫藥大學 |
2011-08 |
CYP2B6 Polymorphisms Influence the Plasma Concentration and Clearance of the Methadone S-Enantiomer
|
(Wang SC);(Ho IK);(Tsou HH);(Tian JN);(Hsiao CF);(Chen CH);(Tan HK);(Lin L);(Wu CS);(Su LW);黃介良(Chieh-Liang Huang);(Yang YH);(Liu ML);(Lin KM);(Chen CY);(Liu SC);(Wu HY);(Chan HW);(sai MH);(Lin PS);(Liu YL)* |
| 國家衛生研究院 |
2011-07 |
A consistency approach to evaluation of bridging studies and multiregional trials
|
Tsou, HH;Chien, TY;Liu, JP;Hsiao, CF |
| 國家衛生研究院 |
2011-05 |
Genetic polymorphisms in PXR associated with serum concentration and metabolism to treatment with the antidepressant paroxetine
|
Liu, YL;Lin, KM;Tsou, HH;Tian, JN;Chen, CH;Shen, WW;Lu, SC;Liu, CY;Hsiao, MC;Tang, HS;Liu, SI;Chang, LH;Hsiao, CF;Kuo, HW;Hsu, YT;Liu, SC;Tu, SL |
| 國家衛生研究院 |
2011-05 |
The genetic polymorphisms in ALDH2 influence the methadone dose and adverse reactions in patients with heroin addiction
|
Tian, JN;Wang, SC;Chen, CH;Tsou, HH;Ho, IK;Chan, HW;Fang, CP;Hsiao, CF;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Wu, JY;Lin, KM;Chen, CY;Liu, SC;Liu, YL |
| 國家衛生研究院 |
2011-05 |
Genetic polymorphisms of CYP2C19 associated with the side effect and serum concentrations of antidepressant paroxetine
|
Chan, HW;Tsou, HH;Tian, JN;Lin, KM;Hsiao, MC;Shen, WW;Lu, ML;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Liu, SC;Chen, CY;Liu, YL |
| 國家衛生研究院 |
2011-05 |
Opioid receptor Mu1 genetic polymorphisms influence QT prolongation and insomnia in methadone maintenance patients
|
Tian, JN;Wang, SC;Ho, IK;Tsou, HH;Lin, KM;Hsiao, CF;Chen, CH;Tan, HKL;Lin, LN;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Chen, CY;Liu, SC;Wu, HY;Kuo, HW;Liu, YL |
| 國家衛生研究院 |
2011-04 |
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment
|
Lin, KM;Chiu, YF;Tsai, IJ;Chen, CH;Shen, WW;Liu, SC;Lu, SC;Liu, CY;Hsiao, MC;Tang, HS;Liu, SI;Chang, LH;Wu, CS;Tsou, HH;Tsai, MH;Chen, CY;Wang, SM;Kuo, HW;Hsu, YT;Liu, YL |
| 國家衛生研究院 |
2010-11 |
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
|
Lin, KM;Tsou, HH;Tsai IJ;Hsiao, MC;Hsiao, CF;Liu CY;Shen, WW;Tang, HS;Fang, CK;Wu, CS;Lu, SC;Kuo, HW;Liu, SC;Chan, HW;Hsu, YT;Tian, JN;Liu, YL |
| 國家衛生研究院 |
2010-07 |
Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials - Asian perspective
|
Tsou, HH;Chow, SC;Lan, KK;Liu, JP;Wang, M;Chern, HD;Ho, LT;Hsiung, CA;Hsiao, CF |
| 國家衛生研究院 |
2010-07 |
Sample size determination for a specific region in a multiregional trial
|
Ko, FS;Tsou, HH;Liu, JP;Hsiao, CF |
| 國家衛生研究院 |
2010-05 |
Validation of the Chinese-Canadian study of health and aging clinical frailty scale (CSHA-CFS) telephone version
|
Chan, DC;Tsou, HH;Chen, CY |
显示项目 76-100 / 109 (共5页)
<< < 1 2 3 4 5 > >>
每页显示[10|25|50]项目
|
